Life Sciences

Tissue strength: bio-medical advances could cut the average cost of drug development by 10 per cent.
Tissue strength: bio-medical advances could cut the average cost of drug development by 10 per cent.
Photographer: Image by University of Oxford

China Invests In World-Class Research At Oxford

3 November 2009
AN INNOVATIVE UK company has secured a one million pounds investment from Hong Kong for its micro-bioreactor technology. read more
Information
Date